STARPHARMA HLDG.SP.ADR/10 Defensive Interval Ratio
STARPHARMA HLDG.SP.ADR/10 defensive interval ratio. STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Defensive Interval Ratio of 282 days as of June 2025. Defensive assets of €4.04 Million (cash €-, short-term investments €-, receivables €4.04 Million) cover 282 days of daily cash needs of €14.32K/day. See STARPHARMA HLDG.SP.ADR/10 (PQ6A) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of STARPHARMA HLDG.SP.ADR/10 (2022–2025)
Defensive interval ratio of STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025. This chart shows how STARPHARMA HLDG.SP.ADR/10's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the ratio stands at 282 days, meaning defensive assets of €4.04 Million can fund 282 days of operations without new revenue. Read debt load of STARPHARMA HLDG.SP.ADR/10 for a breakdown of total debt and financial obligations.
STARPHARMA HLDG.SP.ADR/10 Defensive Interval Ratio by Year (2022–2025)
STARPHARMA HLDG.SP.ADR/10 defensive interval ratio by year from 2022 to 2025. The table below presents the year-by-year Defensive Interval Ratio for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see PQ6A total asset value.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 282 days | €4.04 Million | €14.32K/day | €- | €- | ▼ -52 days |
| 2024 | 334 days | €6.09 Million | €18.25K/day | €- | €- | ▲ +136 days |
| 2023 | 198 days | €7.86 Million | €39.65K/day | €- | €- | ▼ -62 days |
| 2022 | 260 days | €7.29 Million | €28.03K/day | €- | €- | — |